HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?
about
AASLD guidelines for treatment of chronic hepatitis B.Antiviral therapies and prospects for a cure of chronic hepatitis B.Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapyLamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.New paradigms in hepatitis B management: only diamonds are forever.Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
P2860
Q34501660-A9D5AA6C-4187-49B3-9535-9891302AEFBCQ35245231-B618BE65-3585-4BBE-A01B-B516064129F0Q36502057-765A3AAD-6E3F-4360-A777-8FE3BE6D96D6Q36954038-5F9B06EA-CAE8-4E59-9C3F-16FD29663E03Q38588187-049D5570-58F5-4EED-A2C4-79578A30F5F8Q39431420-C8629AB2-1E06-407F-BA63-5AFEC02A57A0Q41646089-E31CAF70-E972-47A3-9219-3847D9018DC4Q54217690-12C7AE38-1DAF-4B3F-8EA4-4610813EDE66
P2860
HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HBeAg-negative chronic hepatit ...... with nucleos(t)ide analogues?
@en
type
label
HBeAg-negative chronic hepatit ...... with nucleos(t)ide analogues?
@en
prefLabel
HBeAg-negative chronic hepatit ...... with nucleos(t)ide analogues?
@en
P2860
P356
P1433
P1476
HBeAg-negative chronic hepatit ...... with nucleos(t)ide analogues?
@en
P2093
Giampaolo Mangia
Mauro Viganò
P2860
P304
P356
10.1111/LIV.12401
P478
34 Suppl 1
P577
2014-02-01T00:00:00Z